期刊文献+

内源性儿茶酚胺参与白细胞介素-2对大鼠离体心脏的作用 被引量:1

ENDOGENOUS CATECHOLAMINE PARTICIPATES IN THE ACTION OF INTERLEUKIN-2 ON THE ISOLATED RAT HEART
暂未订购
导出
摘要 目的 :研究内源性儿茶酚胺是否参与白细胞介素 2 (IL 2 )的心脏作用。方法 :采用Langendorff离体心脏灌流模型 ,观察室性早搏次数、左室发展压 (LVDP)、左室舒张末压 (LVEDP)、心率 (HR)和冠脉流量 (CF)的变化。结果 :① 5 0U/mlIL 2增加离体心脏的室性早搏次数 ,增加LVDP、LVEDP、HR和CF。②利舍平 (reserpine)或普萘洛尔 (propranolol)预处理后 ,5 0U/mlIL 2对离体心脏的作用消失 ;phentolamine预处理后 ,不改变 5 0U/mlIL 2的离体心脏作用。③ 2 0 0U/mlIL 2增加离体心脏的室性早搏次数 ,对LVDP、LVEDP、HR和CF无显著增加作用。④reserpine或 propranolol预处理后 ,2 0 0U/mlIL 2增加离体心脏的室性早搏次数作用不明显 ,LVDP、HR和CF降低、LVEDP增高。结论 :内源性儿茶酚胺介导了IL 2的致离体心脏心律失常、正性变时和变力作用 ,较高浓度的IL 2抑制离体心脏的功能。 Aim: To explore whether endogenous catecholamine participates in the effect of interleukin-2 on the isolated heart. Methods: The number of premature ventricular contraction(PVC),left ventricular developed pressure(LVDP),left ventricular end-diastolic pressure(LVEDP),heart rate(HR)and coronary flow(CF)were recorded in isolated Langendorffperfused rat hearts. Results: ①50 U/ml IL-2 increased the PVC number,LVDP LVEDP,HR and CF.②Pretreatment of reserpine or propranolol abolished the cardiac effect of IL-2 at 50 U/ml,while pretreatment with phentolamine did not change the effect of IL-2.③200 U/ml IL-2increased the number of PVC,but did not increase LVDP,LVEDP,HR and CF.④After pretreatment of reserpine or propranolol,IL-2 failed to increase the number of PVC,but caused decrease of LVDP,HR and CF,and elevation of LVEDP. Conclusion: Endogenous catecholamine mediates the arrhythmogenic,positively chronotropic and inotropic effects of IL-2.IL-2 at 200 U/ml inhibits the cardiac function in the isolated rat heart.
出处 《中国应用生理学杂志》 CAS CSCD 北大核心 2005年第1期51-54,共4页 Chinese Journal of Applied Physiology
基金 浙江省自然科学基金青年人才专项资金资助(RC990 3 8)
关键词 心脏 白细胞介素-2 儿茶酚胺 心律失常 收缩力 heart interleukin-2 catecholamine arrhythmia contractility
  • 相关文献

参考文献10

  • 1Rosenberg S A, Lotze M T, Muul L M, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone[J]. N Engl J Med, 1987, 316(15): 889-897.
  • 2Rosenberg S A, Lotze M T, Yang J C, et al. Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients[J]. Ann Surg, 1989, 210(4): 474-484.
  • 3Finkel M S, Oddis C V, Jacob T D, et al. Negative inotropic effects of cytokines on the heart mediated by nitric oxide[J]. Science, 1992, 257(5068): 387-389.
  • 4Sterin-Borda L, Perez L C, Borda E S, et al. Effects of IL-2 on the myocardium.Participation of the sympathetic system[J]. J Mol Cell Cardiol, 1996, 28(12): 2457-2465.
  • 5Cao C M, Xia Q, Chen Y Y, et al. Opioid receptor-mediated effects of interleukin-2 on the[Ca2+]i transient and contraction in isolated ventricular myocytes of the rat[J]. Pflügers Arch, 2002, 443(4): 635-642.
  • 6Lacosta S, Merali Z, Anisman H. Central monoamine activity following acute and repeated systemic interleukin-2 administration[J]. Neuroimmunomodulation, 2000, 8(2): 83-90.
  • 7Bognar I T, Albrecht S A, Farasaty M, et al. Effects of human recombinant interleukins on stimulation-evoked noradrenaline overflow from the rat perfused spleen[J]. Naunyn Schmiedebergs Arch Pharmacol, 1994, 349(5): 497-502.
  • 8Favalli L, Lanza E, Rozza A, et al. Evaluation of the cardiovascular toxic effect of recombinant interleukin-2 in rats[J]. Anticancer Res, 1990, 10(6): 1693-1698.
  • 9Cao C M, Xia Q, Bruce I C, et al. Interleukin-2 increases activity of Ca2+-ATPase,but decreases its sensitivity to calcium in rat cardiomyocytes[J]. J Pharmacol Exp Ther, 2003, 306(2): 572-580.
  • 10Proebstle T, Mitrovics M, Schneider M, et al. Recombinant interleukin-2 acts like a class I antiarrhythmic drug on human cardiac sodium channels[J]. Pflügers Arch, 1995, 429(4): 462-469.

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部